FADS1 and acute myeloid leukemia: Furthermore, the product of FADS1 ω-6 desaturation, arachidonic acid (AA), has also been implicated in multiple human cancers, including AML where elevated plasma AA levels are associated with adverse risk (2, 11, 12).